Volpara Health

Volpara's groundbreaking breast health software - combined with empowered patients - will unleash a revolution in cancer detection (ASX: VHT).

[Volpara Health @Volpara]

The countdown is on until RSNA 2024! We can’t wait to connect with our customers and peers from around the world to talk strategy, challenges, and opportunities.
Let’s dive into how we can advance early cancer detection through AI and automated solutions. Partner with us and experience the reliability and safety of a team backed by 400+ peer-reviewed papers, trusted by 7,000 facilities, and committed to the success of your entire program—not just the technology.

Come visit us at RSNA 2024. Reserve your appointment now: https://t.co/9Z0lohvCz6

We’re here to collaborate and support your journey.

[Volpara Health @Volpara]

Make 2025 the year you improve how you identify and manage high-risk patients. @RushUniversity did: "We have a 56-year-old patient whose life was changed by understanding her risk and getting access to additional imagining beyond her annual mammogram."

https://t.co/5Q19c8qwpg

[Volpara Health @Volpara]

Is improving clinical decision-making on your 2025 resolutions list? Volpara Scorecard™ will give your team:
✅ Key breast density and risk insights in one view.
✅ Science-based data and alerts when patients meet high-risk thresholds.

https://t.co/xrC0Kzd8Ur

[Volpara Health @Volpara]

"Prior to Volpara's EQUIP reports, I was spending hours collecting data. Now I can spend time improving quality. My experience with this has been wonderful." - @OaklawnCares

Looking to improve your program performance? Learn how: https://t.co/Tmert3TOil

[Volpara Health @Volpara]

“The key is to help technologists not fear AI but to embrace it as a partner.” 💡

That’s how @UofR achieved its mammography quality goals across 12 imaging sites, a mobile van, and 40 technologists.

Learn how: https://t.co/DCSxy1Vbr4

[Volpara Health @Volpara]

@TheImagingWire explored the impact of AI (and, more specifically, Lunit’s AI) on improving accuracy, reducing radiologist workload, and fine-tuning algorithms for better performance.

Learn how AI is shaping the future of breast cancer screening: https://t.co/3dVci4BHnQ

[Volpara Health @Volpara]

Think your eyes can beat @Lunit_AI? 🤔

Test yourself compared to Lunit INSIGHT for Breast via an interactive challenge experience. Let us know your results in the comments. 👇

https://t.co/o8wyvUSRqu

[Volpara Health @Volpara]

As the year draws to a close, I wanted to extend warm holiday wishes from Volpara Health to you. Just as the holiday season is about giving, let's unwrap the potential for a prosperous partnership in 2025 that brings abundant benefits to your patients.

[Volpara Health @Volpara]

Over 25% of patients at @RushUniversity Medical Center are flagged as high-risk for breast cancer—thanks to Volpara® Risk Pathways™. In just two years, 69% of high-risk patients met NCCN Guidelines® for follow-up, leading to improved outcomes.

https://t.co/5Q19c8qwpg

[Volpara Health @Volpara]

In just 24 months, @mySingingRiver achieved:

✔️ 25% of patients met NCCN Guidelines® for genetic testing.
✔️ 36% completed the test onsite, identifying 6% with pathogenic mutations or carrier status.
✔️ 42% received negative genetic results

Learn more: https://t.co/iqZhowS66n

[Volpara Health @Volpara]

Will 2025 be the year you make smarter, more personalized breast care a priority in your organization? Our breast screening software is designed to support your efforts.

Let’s start the new year strong—request a demo: https://t.co/MGd06JGpTM

[Volpara Health @Volpara]

@MemoiralCareHS, a participant in the ACR collective, improved mammography metrics from 92% to 96% in six months, reduced variability by 20%, and boosted quality by 13%—all while sustaining excellence with Volpara Analytics.

Read the full case study: https://t.co/nieWRrSKFy

[Volpara Health @Volpara]

SecondRead AI is a second set of eyes that gives radiologists AND patients peace of mind.  👀

Watch this quick, real-world use case that led to the discovery and confirmation of a high-risk lesion: https://t.co/If7glGm136

[Volpara Health @Volpara]

Big news! Lunit and Rezolut have launched SecondReadAI, an innovative AI-powered tool that provides a second opinion on mammograms. It helps spot subtle details that could be missed and boosts early-stage cancer detection by up to 15%!

Learn more: https://t.co/5jOkfoFS1h

[Volpara Health @Volpara]

Just got back from RSNA, and wow—it was a whirlwind! 🩷

This year marked a big milestone—our first event with @Lunit_AI since joining forces. Together, we unveiled how our combined expertise will shape the future of breast cancer diagnostics.

https://t.co/aYFkdLMCm1

[Volpara Health @Volpara]

"Radiologists used to read images on their own?!" 😱

At RSNA, our CEO Teri Thomas spoke with @MedCityNews about how Volpara and @Lunit_AI are shaping the future of mammography with AI—bringing smarter tools and sharper insights to radiology.

https://t.co/rlXN0g10iZ

[Volpara Health @Volpara]

🚨 Lunit AI was highlighted yesterday during @TheImagingWire Show! Learn from @UCDavisHealth and Mosaic Breast Imaging as they share insights and their experience using @Lunit_AI's AI technology to improve cancer detection.

https://t.co/UkIrQxqb6K

[Volpara Health @Volpara]

Between 2020–2023, nearly 26% of @RushMedical's patients were flagged as an elevated risk, enabling personalized surveillance with advanced imaging options like ABUS and Fast MRI.

Learn how Rush uses our tech to ensure tailored care: https://t.co/5Q19c8qwpg

[Volpara Health @Volpara]

The @UofR is setting the bar high in mammography quality! 📈 Volpara Analytics™ helped them reduce technical repeat rates to as low as 1-2% and foster a culture of recognition and improvement among their 40+ technologists.

https://t.co/DCSxy1Vbr4

[Volpara Health @Volpara]

RSNA is about more than tech—it's about finding partners dedicated to your success! 💡

Look for:
🌱 Customer success managers
🌱 Pro services for smooth implementation
🌱 Online communities & learning tools

Reserve your spot now: https://t.co/GgjISXMQmA

#RSNA2024 #RadiologyInnovation

[Volpara Health @Volpara]

ICYMI: Our new contract with the U.S. Defense Health Agency will enhance screening services for 9.6 million active-duty members, veterans, and their families! 🎉

https://t.co/Z9tHaokLYU